Antenatal Manifestations of Smith-Lemli-Opitz (RSH) Syndrome: a Retrospective Survey of 30 Cases
Overview
Authors
Affiliations
Smith-Lemli-Opitz (SLO) syndrome or RSH syndrome is an autosomal recessive multiple malformation, and mental retardation syndrome ascribed to 7-dehydrocholesterol reductase deficiency, and usually diagnosed in the early postnatal period. Reviewing a series of 30 cases of SLO, we have investigated the variable antenatal expression of the disorder. Intrauterine growth retardation (IUGR) was the most frequent detectable trait (20/30). IUGR was either isolated (9/20) or associated with at least one other anomaly (11/20), including nuchal edema, renal, cardiac, cerebral malformations, genital anomalies, or polydactyly. In this last group, 3/11 presented with multiple malformations (> or =3 anomalies). In 5/30 cases, isolated nuchal edema (3/30), and isolated cardiac (1/30) or renal malformations (1/30) were the only detectable anomalies. Ultrasound findings were considered normal in 5/30 cases and were abnormal in 25/30 cases (83%), but early detection of multiple malformations was rare (3/30, 10%). We suggest giving consideration to a more systematic sterol analysis when dealing with IUGR, especially when associated anomalies are detected.
Antenatal manifestations of inborn errors of metabolism: prenatal imaging findings.
Guibaud L, Collardeau-Frachon S, Lacalm A, Massoud M, Rossi M, Cordier M J Inherit Metab Dis. 2016; 40(1):103-112.
PMID: 27853988 DOI: 10.1007/s10545-016-9992-3.
Antenatal manifestations of inborn errors of metabolism: biological diagnosis.
Vianey-Saban C, Acquaviva C, Cheillan D, Collardeau-Frachon S, Guibaud L, Pagan C J Inherit Metab Dis. 2016; 39(5):611-624.
PMID: 27393412 DOI: 10.1007/s10545-016-9947-8.
Collardeau-Frachon S, Cordier M, Rossi M, Guibaud L, Vianey-Saban C J Inherit Metab Dis. 2016; 39(5):597-610.
PMID: 27106218 DOI: 10.1007/s10545-016-9937-x.
Pathogenesis, Epidemiology, Diagnosis and Clinical Aspects of Smith-Lemli-Opitz Syndrome.
Bianconi S, Cross J, Wassif C, Porter F Expert Opin Orphan Drugs. 2015; 3(3):267-280.
PMID: 25734025 PMC: 4343216. DOI: 10.1517/21678707.2015.1014472.